Skya Bioscience

Skya Bioscience is a San Diego-based biotechnology company dedicated to the discovery and development of precision therapies for oncology and immunology. Founded by Sharat Singh, the former CEO of Prometheus Biosciences, the company leverages a data-driven approach to identify novel targets and patient populations with high unmet medical needs. Skya Bioscience focuses on integrating advanced molecular diagnostics with targeted small molecule drug discovery to create personalized treatment options. The company is currently in the pre-clinical stage, building a pipeline of highly selective candidates designed to modulate key disease-driving pathways. By bridging the gap between diagnostic insights and therapeutic intervention, Skya Bioscience aims to replicate the success of precision medicine in complex inflammatory and malignant diseases.